EUVIMEDEUVIMED entdecken
EditorialKommentarOpen Access

T-Cell Activation and LPS: A Dangerous Duo for Organ Dysfunction

Austin W Kerr, Philip A Efron, Shawn D Larson, Jaimar C Rincon

Journal of Leukocyte Biology · 23.07.2022 · 112 (2) · 219-220

DOI: 10.1002/jlb.3ce0122-019r ↗

Kurz gefasst

Editorial in der Zeitschrift Journal of Leukocyte Biology, online erschienen am 28.04.2022. Verfasst von Austin W Kerr und 3 weiteren Autor:innen. Beteiligte Einrichtung: Sepsis and Critical Illness Research Center, Department of Surgery, University of Florida College of Medicine, Gainesville, FL. Hauptthemen laut MEDLINE: Lipopolysaccharides, Toll-Like Receptor 4. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 13 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lipopolysaccharide (LPS), one of the main components of cell membranes in gram-negative bacteria, is commonly used to promote inflammation-induced organ dysfunction. In the TLR4/LPS pathway, LPS binding protein and CD14 enable lipid A of LPS to be recognized by the TLR4-MD2 receptor complex. The intracellular domain of the TLR4/LPS complex stimulates MyD88-dependent/independent and TRIF-dependent pathways, which in turn activate NF-B and IRF3, leading to subsequent production of pro-inflammatory mediators. LPS has been demonstrated to induce microcirculatory disturbances via promotion of leukocyte adhesion to the vascular endothelium and the release of reactive oxygen species (ROS), damaging the vessels and causing vascular dysfunction. Thus, LPS is frequently used as a systemic model of inflammation as LPS administration increases circulating pro-inflammatory mediators, which triggers leukocyte adhesion and leads to multi-organ failure and death.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LipopolysaccharidesToll-Like Receptor 4HumansInflammationInflammation MediatorsMicrocirculationMultiple Organ FailureMyeloid Differentiation Factor 88Signal TransductionT-Lymphocytes

Substanzen

Inflammation MediatorsLipopolysaccharidesMyeloid Differentiation Factor 88Toll-Like Receptor 4

Autor:innen und Institutionen

  • Sepsis and Critical Illness Research Center, Department of Surgery, University of Florida College of Medicine, Gainesville, FL.

Förderung

  • NIGMS NIH HHS

Zitieren

APA

Kerr, A. W., Efron, P. A., Larson, S. D., & Rincon, J. C. (2022). T-Cell Activation and LPS: A Dangerous Duo for Organ Dysfunction. Journal of Leukocyte Biology, 112(2), 219-220. https://doi.org/10.1002/jlb.3ce0122-019r

Vancouver

Kerr AW, Efron PA, Larson SD, Rincon JC. T-Cell Activation and LPS: A Dangerous Duo for Organ Dysfunction. Journal of Leukocyte Biology. 2022;112(2):219-220. doi:10.1002/jlb.3ce0122-019r

BibTeX
@article{Kerr2022,
  author = {Kerr, Austin W and Efron, Philip A and Larson, Shawn D and Rincon, Jaimar C},
  title = {T-Cell Activation and LPS: A Dangerous Duo for Organ Dysfunction},
  journal = {Journal of Leukocyte Biology},
  year = {2022},
  volume = {112},
  number = {2},
  pages = {219--220},
  doi = {10.1002/jlb.3ce0122-019r}
}
Kostenlos starten →